Article

Lahouassa H, Daddacha W, Hofmann H et al.SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223-228

Institut National de la Santé et de la Recherche Médicale U1016, Institut Cochin, Paris, France.
Nature Immunology (Impact Factor: 24.97). 05/2012; 13(3):223-8. DOI: 10.1038/ni.2236
Source: PubMed

ABSTRACT SAMHD1 restricts the infection of dendritic and other myeloid cells by human immunodeficiency virus type 1 (HIV-1), but in lentiviruses of the simian immunodeficiency virus of sooty mangabey (SIVsm)-HIV-2 lineage, SAMHD1 is counteracted by the virion-packaged accessory protein Vpx. Here we found that SAMHD1 restricted infection by hydrolyzing intracellular deoxynucleoside triphosphates (dNTPs), lowering their concentrations to below those required for the synthesis of the viral DNA by reverse transcriptase (RT). SAMHD1-mediated restriction was alleviated by the addition of exogenous deoxynucleosides. An HIV-1 with a mutant RT with low affinity for dNTPs was particularly sensitive to SAMHD1-mediated restriction. Vpx prevented the SAMHD1-mediated decrease in dNTP concentration and induced the degradation of human and rhesus macaque SAMHD1 but had no effect on mouse SAMHD1. Nucleotide-pool depletion could be a general mechanism for protecting cells from infectious agents that replicate through a DNA intermediate.

Download full-text

Full-text

Available from: Waaqo Daddacha, Aug 23, 2015
0 Followers
 · 
197 Views
  • Source
    • "SAMHD1 is a restriction factor expressed widely in myeloid cell lineages and resting T cells (Baldauf et al., 2012; Laguette et al., 2011). Restriction by SAMHD1 is mediated by reduction of nucleotide pools to levels where reverse transcription cannot proceed, although the restriction mechanism may be more complex than this simple model (Goldstone et al., 2011; Lahouassa et al., 2012). SAMHD1 appears to be particularly important for protecting dendritic cells from HIV-1 infection (Manel et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 was recognized as the cause of AIDS in humans in 1984. Despite 30 years of intensive research, we are still unraveling the molecular details of the host-pathogen interactions that enable this virus to escape immune clearance and cause immunodeficiency. Here we explore a series of recent studies that consider how HIV-1 interacts with the cell-autonomous innate immune system as it navigates its way in and out of host cells. We discuss how these studies improve our knowledge of HIV-1 and host biology as well as increase our understanding of transmission, persistence, and immunodeficiency and the potential for therapeutic or prophylactic interventions.
    Cell Host & Microbe 07/2014; 16(1):10-18. DOI:10.1016/j.chom.2014.06.009 · 12.19 Impact Factor
  • Source
    • "reverse transcriptase (RT) has a relatively high binding affinity for dNTPs, as compared to MLV (Weiss et al., 2004), which facilitates replication in cells with reduced dNTP content such as MDMs (Diamond et al., 2004). In line with this, HIV-1 RT mutant V148I, which has reduced dNTP binding affinity (Diamond et al., 2003, 2004), decreases HIV-1's ability to infect MDMs (Diamond et al., 2004; Lahouassa et al., 2012). Whether the RTs of HIV-2/SIVsmm have lower dNTP binding affinities than HIV-1 RT is currently unknown, but this could contribute to their dependence upon vpx. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vpx is a protein encoded by members of the HIV-2/SIVsmm and SIVrcm/SIVmnd-2 lineages of primate lentiviruses, and is packaged into viral particles. Vpx plays a critical role during the early steps of the viral life cycle and has been shown to counteract SAMHD1, a restriction factor in myeloid and resting T cells. However, it is becoming evident that Vpx is a multifunctional protein in that SAMHD1 antagonism is likely not its sole role. This review summarizes the current knowledge on this X-traordinary protein.
    Frontiers in Microbiology 04/2014; 5:126. DOI:10.3389/fmicb.2014.00126 · 3.94 Impact Factor
  • Source
    • "In contrast, LINE-1 inhibition by SAMHD1 is observed in dividing cells. SAMHD1's dNTPase activity depends on residues H167, H206, D207, and D311 within the HD domain (Aravind and Koonin, 1998; Goldstone et al., 2011; Powell et al., 2011) and is crucial for retroviral inhibition because mutations at H206/D207 compromise both enzymatic activity and antiviral potency (Kim et al., 2012; Laguette et al., 2011; Lahouassa et al., 2012). However, in our study, the D311A mutation, which depletes the hydrolase activity of SAMHD1 (Goldstone et al., 2011), still functions as a LINE-1 inhibitor. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Long interspersed elements 1 (LINE-1) occupy at least 17% of the human genome and are its only active autonomous retrotransposons. However, the host factors that regulate LINE-1 retrotransposition are not fully understood. Here, we demonstrate that the Aicardi-Goutières syndrome gene product SAMHD1, recently revealed to be an inhibitor of HIV/simian immunodeficiency virus (SIV) infectivity and neutralized by the viral Vpx protein, is also a potent regulator of LINE-1 and LINE-1-mediated Alu/SVA retrotransposition. We also found that mutant SAMHD1s of Aicardi-Goutières syndrome patients are defective in LINE-1 inhibition. Several domains of SAMHD1 are critical for LINE-1 regulation. SAMHD1 inhibits LINE-1 retrotransposition in dividing cells. An enzymatic active site mutant SAMHD1 maintained substantial anti-LINE-1 activity. SAMHD1 inhibits ORF2p-mediated LINE-1 reverse transcription in isolated LINE-1 ribonucleoproteins by reducing ORF2p level. Thus, SAMHD1 may be a cellular regulator of LINE-1 activity that is conserved in mammals.
    Cell Reports 09/2013; 4(6). DOI:10.1016/j.celrep.2013.08.019 · 8.36 Impact Factor
Show more